Neri RE, Celis GC, León JS, Gutiérrez EP, Kunhardt UE, L Rosenfield O, Salazar LCC, Velázquez CP

Idioma: Español
Referencias bibliográficas: 39
Paginas: 512-517
Archivo PDF: 296.47 Kb.

RESUMEN

Las infecciones de las vías urinarias son un problema de salud mundial, con una proporción de 9 a 1 en la mujer respecto del hombre. En 90% de los casos la bacteria que la origina es Escherichia coli. Durante la vida reproductiva, esta infección es motivo de gran cantidad de incapacidades laborales, de ahí la necesidad de insistir en su profilaxis. El jugo de arándano rojo es una opción para prevenir la infección de vías urinarias, cualidad demostrada en diferentes publicaciones recientes, en las que se destaca que su mecanismo de acción radica en el efecto que ejercen las proantocianidinas, especialmente las de tipo A, en el urotelio, que evitan que Escherichia coli se adhiera a éste; es así como ejerce su acción antibacteriana, que se consigue con la ingestión de, por lo menos, 300 mL de jugo al día.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Secretaría de Salud, 2007 SUIVE. www.dgepi.salud.gob.mx, 4 sep 2007.

2. Programa Nacional de Salud. Disponibilidad de los servicios de salud y profesionales de la salud. www.salud.gob.mx PNS 2007-2012.

3. Howell AB. Bioactive compounds in cranberries and their role in prevention of urinary tract infections. Mol Nutr Food 2007;51:625-31.

4. Santillo VM, Lowe FC. Cranberry juice for the prevention and treatment of urinary tract infections. Drugs of Today 2007;43(1):47-54.

5. Avron J, Monane M, Gurwitz J, Glynn R. Reduction of bacteriuria and pyuria with cranberry beverage: A randomized trial (abstract). Journal of the American Geriatric Society 1993;41(10 Suppl.):SA13.

6. Jepson RG, Craig JC. A systematic review of evidence for cranberries and blueberries in UTI prevention. Mol Nutr Food Res 2007;51:1-8.

7. Habash MB, van der Mei HC, Reid G, Busscher HJ. The effect of water, ascorbic acid, and cranberry derived supplementation on human urine and uropathogenic adhesion to silicone rubber. Can J Microbiol 1999;45:691-4.

8. Jepson RG, Craig JC. Cranberries for preventing urinary tract infections. Cochrane Database of Systematic Reviews 2008, Issue 1. Art. Núm. CD001321. DOI:10. 1002/14651858. CD001321.pub4.

9. Ofek I, Goldhar J, Zafriri D, Lis H, et al. Anti-Escherichia coli adhesion activity of cranberry and blueberry juices. N Engl JMed 1991;324:1599.

10. Foo LY, Lu Y, Howell AB, Vorsa N. A-type proanthocyanidin trimers from cranberry that inhibit adherence of uropathogenic P-fimbriated Eschrechia coli. J Nat Prod 2000;63:1225-8.

11. Hei F, Pan QH, Shi Y, Duan CQ. Biosynthesis and genetic regulation of proanthocyanidins in plants. Molecules 2008;13(10):2674-703.

12. Gupta K, Chou MY, Howell A, et al. Cranberry products inhibit adherence of p-fimbriated Escherichia coli to primary cultured bladder and vaginal epithelial cells. J Urol 2007;177(6):2357-60.

13. Johnson BJ, Lin B, Dinderman MA, et al. Impact of cranberry on Escherichia coli cellular surface characteristics. Biochem Biophys Res Common 2008;19;377(3):992-4.

14. Sobota AE. Inhibition of bacterial adherence by cranberry juice: Potential use for the treatment of urinary tract infection. J Urol 1984;131:1013-6.

15. Zafriri D, Ofek I, Adar R, et al. Inhibitory activity of cranberry juice on adherence of type 1 and type P fimbriated Escherichia coli to eukaryotic cells. Antimicrob Agents Chemother 1989;33:92-98.

16. Foda MM, Middlebrock PF, Gatfield CT, et al. Efficacy of cranberry in prevention of urinary tract infection in susceptible pediatric population. Can J Urol 1995;2:98-102.

17. Schlager TA, Anderson S, Trudell J, Hendley JO. Effect of cranberry juice on bacteriuria in children with neurogenic bladder receiving intermittent catheterization. J Pediatric 1999;135:698-702.

18. Stothers L. A randomized trial to evaluate effectiveness and cost effectiveness of naturopathic cranberry products as prophylaxis against urinary tract infections in women. Urology 2002;9(3):1558-62.

19. McMurdo ME, Bissett LY, Price RJ, et al. Does ingestion of cranberry juice reduce symptomatic urinary tract infections in older people in hospital? A double- blind, placebo-controlled trial. Age Ageing 2005;34:256-61.

20. Waites KB, Canupp KC, Armstrong S, DeVivo MJ. Effect of cranberry extract on bacteriuria and pyuria in persons with neurogenic bladder secondary to spinal cord injury. J Spin Cord Med 2004;27:29-34.

21. Linsenmeyer TA, Harrison B, Oakley A, et al. Evaluation of cranberry supplement for reduction of urinary tract infections in individuals with neurogenic bladders secondary to spinal cord controlled, crossover injury. A prospective, double-binded, placebo-study. J Spinal Cord Med 2004;27(1):29-34.

22. Kontiokari T, Sundqvist K, Nuutinem M, et al. Randomised trial of cranberry-lingonberry juice and lactobacillus GG drink for the prevention of urinary tract infections in women. BMJ 2001;322:1571-3.

23. Walker EB, Barney DP, Mickelsen JN, et al. Cranberry concentrate: UTI Prophylaxis. J Fam Pract 1997;45:167-8.

24. Arvon J, Monane M, Gurwitz JH, et al. Reduction of bacteriuria and pyuria after ingestion of cranberry juice. JAMA 1994;271:751-4.

25. Gettman MT, Ogan K, Brinkley LJ, et al. Effect of cranberry juice consumption on urinary stone risk factors. J Urol 2005;174:590-4.

26. Kessler T, Jansen B, Hesse A. Effect of blackcurrant, cranberry and plum juice consumption on risk factors associated with kidney stone formation. Eur J Clin Nutr 2002; 56(10):1020-3.

27. McHarg T, Rodgers A, Charlton K. Influence of cranberry juice on the urinary risk factors for calcium oxalate kidney stone formation. BJU Int 2003;92(7):765-8.

28. Paeng CH, Sprague M, Jackevicius CA. Interaction between warfarin and cranberry juice. Clin Ther 2007; 29(8):1730-5.

29. Suvarna R, Pirmohamed M, Henderson L. Possible interaction between warfarin and cranberry juice. BMJ2003;327(7429):1454.

30. Lilja JJ, Backman JT, Neuvonen PJ. Effects of daily ingestion of cranberry juice on the pharmacokinetics of warfarin, tizanidine, and midazolam -probes of CYP2C9, CYP1A2, and CYP3A4. Clin Pharmacol Ther 2007;81(6):833-9.

31. Burger O, Itzhak O, Tabak M, et al. A high molecular mass constituent of cranberry juice inhibits Helicobacter pylori adhesion to human gastric mucus. Federation of European Microbiological Societies 2000;29:295-301.

32. Zhang L, Ma J, Pan K, et al. Efficacy of cranberry juice on Helicobacter pylori infection: a double-blind, randomized placebo-controlled trial. Helicobacter 2005;10(2):139-45.

33. Shmuely H, Yahav J, Samra Z, et al. Effect of cranberry juice on erradication of Helicobacter pylori in patients treated with antibiotics and a proton pump inhibitor. Mol Nutr Food Res 2007;51(6):746-51.

34. Mckay DL, Blumberg JB. Cranberries (Vaccinium macrocarpon) and cardiovascular disease risk factors. Nutrition Reviews 2007;65(11):490-502.

35. Wilson T, Porcari JP, Harbin D. Cranberry extract inhibits low density lipoprotein oxidation. Life Sciences 1998; 62(24):381-6.

36. Weiss El, Lev-Dor R, Kashmamn Y, et al. Inhibiting interspecies coaggregation of plaque bacteria with a cranberry juice constituent. Journal of the American Dental Association 1998;129:1719-23.

37. Yamanaka A, Kimizuka R, Kato T, Okuda K. Inhibitory effects of cranberry juice on attachment of oral streptococci and biofilm formation. Journal of Oral Microbiol Immunology 2004;19(3):150-4.

38. Neto CC, Krueger CG, Lamoureaux TL, et al. Maldit of MS characterization of proanthocyanidins from cranberry fruit (vaccinium macrocarpon) that inibit tumor cell growth and matrix metalloproteinase expression in vitro. Journal of the Science of Food and Agriculture 2006;86:18-25.

39. Neto CC. Cranberry and its phytochemicals: A review of in vitro anticancer studies. The Journal of Nutrition (Supplement: International Research Conference on food, nutrition and cancer, Washington, D.C. July 2006); 0022-3166/07 (2007).